Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1995 Jul;39(7):1391–1397. doi: 10.1128/aac.39.7.1391

Antifungal agents in neonatal systemic candidiasis.

J N van den Anker 1, N M van Popele 1, P J Sauer 1
PMCID: PMC162751  PMID: 7492074

Full Text

The Full Text of this article is available as a PDF (179.9 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baley J. E., Kliegman R. M., Boxerbaum B., Fanaroff A. A. Fungal colonization in the very low birth weight infant. Pediatrics. 1986 Aug;78(2):225–232. [PubMed] [Google Scholar]
  2. Baley J. E., Kliegman R. M., Fanaroff A. A. Disseminated fungal infections in very low-birth-weight infants: therapeutic toxicity. Pediatrics. 1984 Feb;73(2):153–157. [PubMed] [Google Scholar]
  3. Baley J. E., Meyers C., Kliegman R. M., Jacobs M. R., Blumer J. L. Pharmacokinetics, outcome of treatment, and toxic effects of amphotericin B and 5-fluorocytosine in neonates. J Pediatr. 1990 May;116(5):791–797. doi: 10.1016/s0022-3476(05)82674-5. [DOI] [PubMed] [Google Scholar]
  4. Bardare M., Tortorano A. M., Pietrogrande M. C., Viviani M. A. Pharmacokinetics of ketoconazole and treatment evaluation in candidal infections. Arch Dis Child. 1984 Nov;59(11):1068–1071. doi: 10.1136/adc.59.11.1068. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Barone J. A., Koh J. G., Bierman R. H., Colaizzi J. L., Swanson K. A., Gaffar M. C., Moskovitz B. L., Mechlinski W., Van de Velde V. Food interaction and steady-state pharmacokinetics of itraconazole capsules in healthy male volunteers. Antimicrob Agents Chemother. 1993 Apr;37(4):778–784. doi: 10.1128/aac.37.4.778. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Bektas S., Goetze B., Speer C. P. Decreased adherence, chemotaxis and phagocytic activities of neutrophils from preterm neonates. Acta Paediatr Scand. 1990 Nov;79(11):1031–1038. doi: 10.1111/j.1651-2227.1990.tb11379.x. [DOI] [PubMed] [Google Scholar]
  7. Bergman K. A., Meis J. F., Horrevorts A. M., Monnens L. Acute renal failure in a neonate due to pelviureteric candidal bezoars successfully treated with long-term systemic fluconazole. Acta Paediatr. 1992 Sep;81(9):709–711. doi: 10.1111/j.1651-2227.1992.tb12342.x. [DOI] [PubMed] [Google Scholar]
  8. Bhandari V., Narang A. Oral itraconazole therapy for disseminated candidiasis in low birth weight infants. J Pediatr. 1992 Feb;120(2 Pt 1):330–330. doi: 10.1016/s0022-3476(05)80456-1. [DOI] [PubMed] [Google Scholar]
  9. Bodé S., Pedersen-Bjergaard L., Hjelt K. Candida albicans septicemia in a premature infant successfully treated with oral fluconazole. Scand J Infect Dis. 1992;24(5):673–675. doi: 10.3109/00365549209054656. [DOI] [PubMed] [Google Scholar]
  10. Butler K. M., Baker C. J. Candida: an increasingly important pathogen in the nursery. Pediatr Clin North Am. 1988 Jun;35(3):543–563. doi: 10.1016/s0031-3955(16)36471-9. [DOI] [PubMed] [Google Scholar]
  11. Butler K. M., Rench M. A., Baker C. J. Amphotericin B as a single agent in the treatment of systemic candidiasis in neonates. Pediatr Infect Dis J. 1990 Jan;9(1):51–56. doi: 10.1097/00006454-199001000-00012. [DOI] [PubMed] [Google Scholar]
  12. Chesney P. J., Justman R. A., Bogdanowicz W. M. Candida meningitis in newborn infants: a review and report of combined amphotericin B--flucytosine therapy. Johns Hopkins Med J. 1978 May;142(5):155–160. [PubMed] [Google Scholar]
  13. Christiansen K. J., Bernard E. M., Gold J. W., Armstrong D. Distribution and activity of amphotericin B in humans. J Infect Dis. 1985 Nov;152(5):1037–1043. doi: 10.1093/infdis/152.5.1037. [DOI] [PubMed] [Google Scholar]
  14. Cotton M. F., Ransome O. J. Oral ketoconazole and flucytosine for neonatal systemic candidiasis. S Afr Med J. 1989 Apr 15;75(8):388–389. [PubMed] [Google Scholar]
  15. Cruciani M., Di Perri G., Molesini M., Vento S., Concia E., Bassetti D. Use of fluconazole in the treatment of Candida albicans hydrocephalus shunt infection. Eur J Clin Microbiol Infect Dis. 1992 Oct;11(10):957–957. doi: 10.1007/BF01962387. [DOI] [PubMed] [Google Scholar]
  16. D'Ambola J. B., Sherman M. P., Tashkin D. P., Gong H., Jr Human and rabbit newborn lung macrophages have reduced anti-Candida activity. Pediatr Res. 1988 Sep;24(3):285–290. doi: 10.1203/00006450-198809000-00001. [DOI] [PubMed] [Google Scholar]
  17. Diasio R. B., Lakings D. E., Bennett J. E. Evidence for conversion of 5-fluorocytosine to 5-fluorouracil in humans: possible factor in 5-fluorocytosine clinical toxicity. Antimicrob Agents Chemother. 1978 Dec;14(6):903–908. doi: 10.1128/aac.14.6.903. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Duffty P., Lloyd D. J. Neonatal systemic candidiasis. Arch Dis Child. 1983 Apr;58(4):318–319. doi: 10.1136/adc.58.4.318. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Faix R. G. Invasive neonatal candidiasis: comparison of albicans and parapsilosis infection. Pediatr Infect Dis J. 1992 Feb;11(2):88–93. [PubMed] [Google Scholar]
  20. Faix R. G. Systemic Candida infections in infants in intensive care nurseries: high incidence of central nervous system involvement. J Pediatr. 1984 Oct;105(4):616–622. doi: 10.1016/s0022-3476(84)80433-3. [DOI] [PubMed] [Google Scholar]
  21. Fan-Havard P., Capano D., Smith S. M., Mangia A., Eng R. H. Development of resistance in candida isolates from patients receiving prolonged antifungal therapy. Antimicrob Agents Chemother. 1991 Nov;35(11):2302–2305. doi: 10.1128/aac.35.11.2302. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Frenkel L., Bryson Y. J. Ontogeny of phytohemagglutinin-induced gamma interferon by leukocytes of healthy infants and children: evidence for decreased production in infants younger than 2 months of age. J Pediatr. 1987 Jul;111(1):97–100. doi: 10.1016/s0022-3476(87)80353-0. [DOI] [PubMed] [Google Scholar]
  23. Ginsburg C. M., McCracken G. H., Jr, Olsen K. Pharmacology of ketoconazole suspension in infants and children. Antimicrob Agents Chemother. 1983 May;23(5):787–789. doi: 10.1128/aac.23.5.787. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Grant S. M., Clissold S. P. Fluconazole. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in superficial and systemic mycoses. Drugs. 1990 Jun;39(6):877–916. doi: 10.2165/00003495-199039060-00006. [DOI] [PubMed] [Google Scholar]
  25. Hostetler J. S., Hanson L. H., Stevens D. A. Effect of cyclodextrin on the pharmacology of antifungal oral azoles. Antimicrob Agents Chemother. 1992 Feb;36(2):477–480. doi: 10.1128/aac.36.2.477. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Johnson D. E., Thompson T. R., Green T. P., Ferrieri P. Systemic candidiasis in very low-birth-weight infants (less than 1,500 grams). Pediatrics. 1984 Feb;73(2):138–143. [PubMed] [Google Scholar]
  27. Jones J. M. Laboratory diagnosis of invasive candidiasis. Clin Microbiol Rev. 1990 Jan;3(1):32–45. doi: 10.1128/cmr.3.1.32. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Kauffman C. A., Frame P. T. Bone marrow toxicity associated with 5-fluorocytosine therapy. Antimicrob Agents Chemother. 1977 Feb;11(2):244–247. doi: 10.1128/aac.11.2.244. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Koren G., Lau A., Kenyon C. F., Kroppert D., Klein J. Clinical course and pharmacokinetics following a massive overdose of amphotericin B in a neonate. J Toxicol Clin Toxicol. 1990;28(3):371–378. doi: 10.3109/15563659008994438. [DOI] [PubMed] [Google Scholar]
  30. Koren G., Lau A., Klein J., Golas C., Bologa-Campeanu M., Soldin S., MacLeod S. M., Prober C. Pharmacokinetics and adverse effects of amphotericin B in infants and children. J Pediatr. 1988 Sep;113(3):559–563. doi: 10.1016/s0022-3476(88)80653-x. [DOI] [PubMed] [Google Scholar]
  31. Lackner H., Schwinger W., Urban C., Müller W., Ritschel E., Reiterer F., Kuttnig-Haim M., Urlesberger B., Hauer C. Liposomal amphotericin-B (AmBisome) for treatment of disseminated fungal infections in two infants of very low birth weight. Pediatrics. 1992 Jun;89(6 Pt 2):1259–1261. [PubMed] [Google Scholar]
  32. Leibovitz E., Iuster-Reicher A., Amitai M., Mogilner B. Systemic candidal infections associated with use of peripheral venous catheters in neonates: a 9-year experience. Clin Infect Dis. 1992 Feb;14(2):485–491. doi: 10.1093/clinids/14.2.485. [DOI] [PubMed] [Google Scholar]
  33. Lewis J. H., Zimmerman H. J., Benson G. D., Ishak K. G. Hepatic injury associated with ketoconazole therapy. Analysis of 33 cases. Gastroenterology. 1984 Mar;86(3):503–513. [PubMed] [Google Scholar]
  34. Lin A. C., Goldwasser E., Bernard E. M., Chapman S. W. Amphotericin B blunts erythropoietin response to anemia. J Infect Dis. 1990 Feb;161(2):348–351. doi: 10.1093/infdis/161.2.348. [DOI] [PubMed] [Google Scholar]
  35. Loke H. L., Verber I., Szymonowicz W., Yu V. Y. Systemic candidiasis and pneumonia in preterm infants. Aust Paediatr J. 1988 Apr;24(2):138–142. doi: 10.1111/j.1440-1754.1988.tb00306.x. [DOI] [PubMed] [Google Scholar]
  36. Lopez-Berestein G., Bodey G. P., Fainstein V., Keating M., Frankel L. S., Zeluff B., Gentry L., Mehta K. Treatment of systemic fungal infections with liposomal amphotericin B. Arch Intern Med. 1989 Nov;149(11):2533–2536. [PubMed] [Google Scholar]
  37. Nirasawa M., Sugaya N., Mitamura K., Komiyama T., Kikuchi H., Oikawa T. Serum amphotericin B concentration in a very premature infant with disseminated candidiasis. Keio J Med. 1989 Sep;38(3):319–324. doi: 10.2302/kjm.38.319. [DOI] [PubMed] [Google Scholar]
  38. Odds F. C. Resistance of yeasts to azole-derivative antifungals. J Antimicrob Chemother. 1993 Apr;31(4):463–471. doi: 10.1093/jac/31.4.463. [DOI] [PubMed] [Google Scholar]
  39. Ormälä T., Korppi M., Katila M. L., Ojanen T., Heinonen K. Fungal gut colonization with Candida or Pityrosporum sp. and serum Candida antigen in preterm neonates with very low birth weights. Scand J Infect Dis. 1992;24(6):781–785. doi: 10.3109/00365549209062464. [DOI] [PubMed] [Google Scholar]
  40. Pappu-Katikaneni L. D., Rao K. P., Banister E. Gastrointestinal colonization with yeast species and Candida septicemia in very low birth weight infants. Mycoses. 1990 Jan;33(1):20–23. doi: 10.1111/myc.1990.33.1.20. [DOI] [PubMed] [Google Scholar]
  41. Phillips G., Golledge C. Fungal infection in neonates. J Antimicrob Chemother. 1991 Aug;28(2):159–161. doi: 10.1093/jac/28.2.159. [DOI] [PubMed] [Google Scholar]
  42. Polak A. Pharmacokinetics of amphotericin B and flucytosine. Postgrad Med J. 1979 Sep;55(647):667–670. doi: 10.1136/pgmj.55.647.667. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Pont A., Graybill J. R., Craven P. C., Galgiani J. N., Dismukes W. E., Reitz R. E., Stevens D. A. High-dose ketoconazole therapy and adrenal and testicular function in humans. Arch Intern Med. 1984 Nov;144(11):2150–2153. [PubMed] [Google Scholar]
  44. Sandven P., Bjørneklett A., Maeland A. Susceptibilities of Norwegian Candida albicans strains to fluconazole: emergence of resistance. The Norwegian Yeast Study Group. Antimicrob Agents Chemother. 1993 Nov;37(11):2443–2448. doi: 10.1128/aac.37.11.2443. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Saxén H., Hoppu K., Pohjavuori M. Pharmacokinetics of fluconazole in very low birth weight infants during the first two weeks of life. Clin Pharmacol Ther. 1993 Sep;54(3):269–277. doi: 10.1038/clpt.1993.147. [DOI] [PubMed] [Google Scholar]
  46. Sharp A. M., Odds F. C., Evans E. G. Candida strains from neonates in a special care baby unit. Arch Dis Child. 1992 Jan;67(1 Spec No):48–52. doi: 10.1136/adc.67.1_spec_no.48. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Sherertz R. J., Gledhill K. S., Hampton K. D., Pfaller M. A., Givner L. B., Abramson J. S., Dillard R. G. Outbreak of Candida bloodstream infections associated with retrograde medication administration in a neonatal intensive care unit. J Pediatr. 1992 Mar;120(3):455–461. doi: 10.1016/s0022-3476(05)80920-5. [DOI] [PubMed] [Google Scholar]
  48. Smith H., Congdon P. Neonatal systemic candidiasis. Arch Dis Child. 1985 Apr;60(4):365–369. doi: 10.1136/adc.60.4.365. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Smith S. D., Tagge E. P., Miller J., Cheu H., Sukarochana K., Rowe M. I. The hidden mortality in surgically treated necrotizing enterocolitis: fungal sepsis. J Pediatr Surg. 1990 Oct;25(10):1030–1033. doi: 10.1016/0022-3468(90)90212-r. [DOI] [PubMed] [Google Scholar]
  50. Sonino N. The use of ketoconazole as an inhibitor of steroid production. N Engl J Med. 1987 Sep 24;317(13):812–818. doi: 10.1056/NEJM198709243171307. [DOI] [PubMed] [Google Scholar]
  51. Stamm A. M., Diasio R. B., Dismukes W. E., Shadomy S., Cloud G. A., Bowles C. A., Karam G. H., Espinel-Ingroff A. Toxicity of amphotericin B plus flucytosine in 194 patients with cryptococcal meningitis. Am J Med. 1987 Aug;83(2):236–242. doi: 10.1016/0002-9343(87)90691-7. [DOI] [PubMed] [Google Scholar]
  52. Starke J. R., Mason E. O., Jr, Kramer W. G., Kaplan S. L. Pharmacokinetics of amphotericin B in infants and children. J Infect Dis. 1987 Apr;155(4):766–774. doi: 10.1093/infdis/155.4.766. [DOI] [PubMed] [Google Scholar]
  53. Sánchez P. J., Siegel J. D., Fishbein J. Candida endocarditis: successful medical management in three preterm infants and review of the literature. Pediatr Infect Dis J. 1991 Mar;10(3):239–243. [PubMed] [Google Scholar]
  54. Vaudry W. L., Tierney A. J., Wenman W. M. Investigation of a cluster of systemic Candida albicans infections in a neonatal intensive care unit. J Infect Dis. 1988 Dec;158(6):1375–1379. doi: 10.1093/infdis/158.6.1375. [DOI] [PubMed] [Google Scholar]
  55. Viscoli C., Castagnola E., Corsini M., Gastaldi R., Soliani M., Terragna A. Fluconazole therapy in an underweight infant. Eur J Clin Microbiol Infect Dis. 1989 Oct;8(10):925–926. doi: 10.1007/BF01963785. [DOI] [PubMed] [Google Scholar]
  56. Viscoli C., Castagnola E., Fioredda F., Ciravegna B., Barigione G., Terragna A. Fluconazole in the treatment of candidiasis in immunocompromised children. Antimicrob Agents Chemother. 1991 Feb;35(2):365–367. doi: 10.1128/aac.35.2.365. [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. Ward R. M., Sattler F. R., Dalton A. S., Jr Assessment of antifungal therapy in an 800-gram infant with candidal arthritis and osteomyelitis. Pediatrics. 1983 Aug;72(2):234–238. [PubMed] [Google Scholar]
  58. Weese-Mayer D. E., Fondriest D. W., Brouillette R. T., Shulman S. T. Risk factors associated with candidemia in the neonatal intensive care unit: a case-control study. Pediatr Infect Dis J. 1987 Feb;6(2):190–196. doi: 10.1097/00006454-198702000-00009. [DOI] [PubMed] [Google Scholar]
  59. Wiest D. B., Fowler S. L., Garner S. S., Simons D. R. Fluconazole in neonatal disseminated candidiasis. Arch Dis Child. 1991 Aug;66(8):1002–1002. doi: 10.1136/adc.66.8.1002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  60. Wilson C. B. Immunologic basis for increased susceptibility of the neonate to infection. J Pediatr. 1986 Jan;108(1):1–12. doi: 10.1016/s0022-3476(86)80761-2. [DOI] [PubMed] [Google Scholar]
  61. Zenker P. N., Rosenberg E. M., Van Dyke R. B., Rabalais G. P., Daum R. S. Successful medical treatment of presumed Candida endocarditis in critically ill infants. J Pediatr. 1991 Sep;119(3):472–477. doi: 10.1016/s0022-3476(05)82067-0. [DOI] [PubMed] [Google Scholar]
  62. van den Anker J. N. Treatment of neonatal Candida albicans septicemia with itraconazole. Pediatr Infect Dis J. 1992 Aug;11(8):684–685. [PubMed] [Google Scholar]
  63. van den Anker J. N., van Lingen R. A., Koster M., Heykants J., Sauer P. J. Insufficient ketoconazole concentrations in preterm infants with fungal infections. Eur J Pediatr. 1993 Jun;152(6):538–538. doi: 10.1007/BF01955070. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES